QRISK2 Cardiovascular: How the Score Relates to Heart Disease Risk

QRISK2 is a clinical algorithm used across the UK to quantify an individual’s cardiovascular risk, specifically, the probability of experiencing a heart attack or stroke within the next 10 years. This article takes a detailed look at how QRISK2 relates to cardiovascular disease specifically, what the score captures about your heart health, and what it does not.

What QRISK2 Measures in Cardiovascular Terms

QRISK2 was designed with one specific cardiovascular objective: to estimate the 10-year risk of a first major atherosclerotic cardiovascular event. The events it predicts are:

Myocardial infarction (heart attack)
Ischaemic stroke
Transient ischaemic attack (TIA or “mini-stroke”)
Angina requiring coronary intervention

It does not predict haemorrhagic stroke, heart failure, arrhythmia, or peripheral arterial disease as primary endpoints, though these conditions often share the same risk factor profile.

The score operates by comparing an individual’s risk factor profile against the outcomes observed in the QRESEARCH database, a longitudinal dataset of over 2 million anonymised patient records from UK general practices. This allows the algorithm to estimate what proportion of people with your particular combination of characteristics experienced a cardiovascular event within 10 years.

The Cardiovascular Risk Factors QRISK2 Captures

Lipid-related factors: The total cholesterol-to-HDL ratio is the lipid measure used in QRISK2. This ratio is a more sensitive predictor of cardiovascular risk than total cholesterol alone because it accounts for the balance between atherogenic (LDL) and protective (HDL) cholesterol.

Haemodynamic factors: Systolic blood pressure is included as a continuous variable. Even modest increases in systolic blood pressure carry meaningful increases in cardiovascular risk across a population, a 10 mmHg increase in systolic blood pressure is associated with approximately a 25% increase in stroke risk.

Metabolic factors: Both type 1 and type 2 diabetes are included. Diabetes approximately doubles cardiovascular risk through multiple mechanisms: glycosylation of arterial walls, dyslipidaemia, and accelerated atherosclerosis.

Cardiac conditions: Atrial fibrillation, an irregular heart rhythm, significantly increases stroke risk (approximately five-fold) and is explicitly captured in QRISK2.

Inflammatory conditions: Rheumatoid arthritis is included as an independent cardiovascular risk factor, reflecting research showing that chronic systemic inflammation accelerates atherosclerosis even in the absence of other traditional risk factors.

Renal factors: Chronic kidney disease (CKD) is included because impaired renal function is independently associated with cardiovascular risk through multiple pathways including hypertension, dyslipidaemia, and chronic inflammation.

The Cardiovascular Significance of Deprivation in QRISK2

One of QRISK2’s distinguishing features is the inclusion of social deprivation via the Townsend deprivation score. This reflects robust epidemiological evidence that cardiovascular disease is strongly socially patterned, people in more deprived areas experience higher rates of hypertension, smoking, obesity, type 2 diabetes, and cardiovascular mortality, even after adjusting for individual clinical risk factors.

Including deprivation makes QRISK2 more accurate at a population level, and it also makes it a more socially meaningful tool than algorithms that consider only biomedical variables.

What QRISK2 Does Not Capture About Cardiovascular Health

QRISK2 is a powerful but incomplete picture of cardiovascular risk. Clinically important factors not captured include:

Lipoprotein(a) [Lp(a)], an independent, largely genetic cardiovascular risk factor that contributes significantly to risk in some individuals regardless of standard lipid levels
High-sensitivity CRP (hs-CRP), a marker of low-level systemic inflammation that predicts cardiovascular events independently of cholesterol and blood pressure
Coronary artery calcium (CAC) score, imaging-based measure of actual atherosclerotic burden; far more specific than any risk calculator
Endothelial function, the health and flexibility of the arterial wall is not captured by any blood test or questionnaire
Sleep quality and duration, increasingly recognised as an independent cardiovascular risk factor
Psychological stress, chronic psychological stress contributes to cardiovascular risk through multiple hormonal, inflammatory, and behavioural pathways

What to Do with a High QRISK2 Score

If your GP has discussed a high QRISK2 score with you, the clinical conversation should include:

Identifying which risk factors are driving the score most significantly
Establishing a personalised plan for modifiable risk factor reduction
Discussion of statin therapy, which NICE recommends offering to those with a QRISK2 or QRISK3 score of 10% or above

A high QRISK2 score is a prompt for action, not a prediction of inevitable illness.

A Herbal Medicine Perspective on Cardiovascular Risk Factors

At Herba Naturalle, cardiovascular risk is understood through the physiological lens of three interconnected layers: the digestive system, the surface nervous system, and the smooth muscle lining of the blood vessels. Chronic inflammation in the vascular smooth muscle layer is the structural mechanism underlying atherosclerosis, the narrowing and hardening of the arteries that drives cardiovascular events.

Addressing the root inflammatory drivers, alongside the conventional risk factors captured in QRISK2, is central to Anjela Jeganathan’s 30-year clinical approach.

Read more at About Herbal Medicine or explore the Berberis Plus and Marshmallow Root Plus for digestive and smooth muscle lining support.

Contact the clinic to discuss a herbal approach to cardiovascular health.

The Herba Naturalle 3-Step Bundle

The Herba Naturalle Bundle addresses cardiovascular risk at its physiological root through three steps:

Step 1, Restore Digestion: Reduces toxic and inflammatory burden contributing to dyslipidaemia and vascular inflammation.

Step 2, Calm the Surface Nervous System: The Nervous System Reset reduces the chronic sympathetic activation that drives elevated blood pressure and vascular stress.

Step 3, Heal the Smooth Muscle Lining: The Smooth Muscle and Immune Reset Bundle targets the arterial wall inflammation that is the structural root of cardiovascular disease.

This article is for informational purposes only. Please consult your GP for a personal cardiovascular risk assessment and to discuss any clinical decisions.